Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

"Individer som har modet att engagera sig måste belönas"

Sara Gunnerås, director business and finance, SwedenBio kommenterar det femte förslaget om Skärp målsättningen för deltagande i EU:s ramprogram.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

”Ett perfekt möte på hösten”

"Som vanligt är jag mest sugen på det oväntade". Så svarar Johan Rockberg, professor vid KTH, på frågan om vad han ser mest fram emot på kongressen Bioscience s...

Acadia drug awarded

Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.

Norwegian describes scrapie gene

Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Relax at the After Fair

Round off the first day of the fair by visiting the After Fair. You can reload with entertainment from talented artists such as Patrik Isaksson, The Gentlemen a...

Studie: AI-system lika bra som patologer på diagnos av prostatacancer

AI-system kan identifiera och gradera prostatacancer i vävnadsprover lika bra som patologer. Det menar forskare på bland annat Karolinska institutet som genomfö...

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Så försvarar du företaget mot årets säkerhetshot

Det globala tekniktjänstföretaget NTT Ltd. har identifierat fem cybersäkerhetshot som kan komma att prägla 2022 och hur man skyddar sig mot dem.

De får Laskerpriset för upptäckten bakom mRNA-vaccinen

Årets Laskerpris inom klinisk forskning går till två forskare som banade väg för mRNA-tekniken – och som därmed möjliggjorde den rekordsnabba utvecklingen av de...

Cellforskning belönas med Arrhenius-plaketten

Biokemisten David Drew vid Stockholms universitet mottar Arrhenius-plaketten för forskning om Solute Carrier-transportörer.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Norrländsk life science går för högtryck

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...